Reviews practical challenges clinicians face when prescribing pharmacotherapy for female sexual dysfunctions, including bremelanotide. Discusses barriers such as lack of training, patient discomfort discussing sexual health, insurance coverage limitations, and the modest effect sizes of approved drugs—providing a realistic framework for clinical implementation.
Nappi, Rossella E; Gardella, Barbara